abstract |
Methods of producing a carbohydrate HIV vaccine or immunogenic composition are provided. One method comprises expressing a glycoprotein with a modified glycosylation, which facilitates binding of the glycoprotein to the 2Gl 2 antibody. Another method comprises iteratively selecting cells with a high affinity for the 2Gl 2 antibody. |